Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) Shares Outstanding (Diluted Average) (2016 - 2019)

AC Immune has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $933.76 for Q3 2019.

  • Quarterly Shares Outstanding (Diluted Average) changed N/A to $933.76 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $933.76 through Sep 2019, changed N/A year-over-year, with the annual reading at $57.9 million for FY2017, 15.49% up from the prior year.
  • Shares Outstanding (Diluted Average) was $933.76 for Q3 2019 at AC Immune, up from $668.2 in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $257.7 million in Q2 2016 and troughed at $668.2 in Q2 2019.
  • The 4-year median for Shares Outstanding (Diluted Average) is $48.3 million (2015), against an average of $68.7 million.
  • Year-over-year, Shares Outstanding (Diluted Average) grew 7.67% in 2016 and then rose 15.49% in 2017.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $46.5 million in 2015, then increased by 7.67% to $50.1 million in 2016, then grew by 15.49% to $57.9 million in 2017, then crashed by 100.0% to $933.76 in 2019.
  • Per Business Quant, the three most recent readings for ACIU's Shares Outstanding (Diluted Average) are $933.76 (Q3 2019), $668.2 (Q2 2019), and $57.9 million (Q4 2017).